Literature DB >> 807986

Primary congenital aphakia and the rubella syndrome.

C Vermeif-Keers.   

Abstract

Four embryos from women infected by rubella virus early in pregnancy were investigated histologically. In three of the patients the serological tests were positive; in the fourth the diagnosis of rubella was based solely on the clinical picture. Three of the four embryos showed unilateral severe microphthalmia and primary congenital aphakia. In addition to this defect the right eye of one of the embryos showed a central liquefaction of the lens (cataract). Damage to the internal ear in the form of discontinuities in the epithelium of the cochlear duct were also observed (in two of the three embryos; in the fourth both internal ears were absent in the curettage material). In three of the four hearts there were cells in the myocardium with a markedly eosinophilic cytoplasm.

Entities:  

Mesh:

Year:  1975        PMID: 807986     DOI: 10.1002/tera.1420110305

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  3 in total

1.  Clinicopathological correlation of congenital corneal opacification using ultrasound biomicroscopy.

Authors:  K K Nischal; J Naor; V Jay; L D MacKeen; D S Rootman
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Ultrasound prenatal diagnosis of congenital primary aphakia: case report.

Authors:  Filippo Di Meglio; Carmine Vascone; Letizia Di Meglio; Luigi Carlo Lo Turco; Salvatore Giovanni Vitale; Pietro Cignini; Gaetano Valenti; Ferdinando Antonio Gulino; Agnese Maria Chiara Rapisarda; Stefano Cianci
Journal:  J Prenat Med       Date:  2015 Jan-Jun

3.  Impaired GSH biosynthesis disrupts eye development, lens morphogenesis and PAX6 function.

Authors:  Brian Thompson; Ying Chen; Emily A Davidson; Rolando Garcia-Milian; Jaya Prakash Golla; Nicholas Apostolopoulos; David J Orlicky; Kevin Schey; David C Thompson; Vasilis Vasiliou
Journal:  Ocul Surf       Date:  2021-08-20       Impact factor: 6.268

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.